Early failure of prosthetic valve presenting with acute heart failure

Main Article Content

P Candela*
L Ajello
MCE Valerio
P Camarda
V Mineo
EV Castelluccio
E Rebulla

Abstract

Background: Early failure of cardiac biological prostheses refers to the deterioration or malfunction of the valve sooner than expected. These prostheses are designed to last for many years, even decades, but in some cases, they may fail within a much shorter timeframe. Early failure can manifest in various ways, including structural issues, valve stenosis, regurgitation, and reduced functionality. Understanding the causes of early failure is crucial for improving patient outcomes.


Case presentation: We present the case of failure of a biological prosthesis implanted five years prior; the onset was rapid and acute (worsening dyspnea three days before access to the emergency room). A transcatheter mitral valve replacement was planned. Unfortunately, the patient expired before the procedure.


Discussion: Although rare, early failure of biological valve prosthesis is possible. So, when treating a patient with a history of valve surgery presenting with acute heart failure, the suspicion of valve failure should be always considered.

Downloads

Download data is not yet available.

Article Details

Candela, P., Ajello, L., Valerio, M., Camarda, P., Mineo, V., Castelluccio, E., & Rebulla, E. (2023). Early failure of prosthetic valve presenting with acute heart failure. Journal of Cardiovascular Medicine and Cardiology, 10(4), 051–053. https://doi.org/10.17352/2455-2976.000201
Case Report(s)

Copyright (c) 2024 Candela P, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Hensey M, Brown RA, Lal S, Sathananthan J, Ye J, Cheung A, Blanke P, Leipsic J, Moss R, Boone R, Webb JG. Transcatheter Mitral Valve Replacement: An Update on Current Techniques, Technologies, and Future Directions. JACC Cardiovasc Interv. 2021 Mar 8;14(5):489-500. doi: 10.1016/j.jcin.2020.12.038. Epub 2021 Mar 1. PMID: 33663778.

Mitral valve regurgitation. Symptoms and causes. Mayo Clinic. [cited 2023 Nov.6]. https://www.mayoclinic.org/diseases-conditions/mitral-valve-regurgitation/symptoms-causes/syc-20350178.

Enta Y, Nakamura M. Transcatheter mitral valve replacement. J Cardiol. 2021 Jun;77(6):555-564. doi: 10.1016/j.jjcc.2020.10.020. Epub 2020 Nov 25. PMID: 33248865.

Pibarot P, Herrmann HC, Wu C, Hahn RT, Otto CM, Abbas AE, Chambers J, Dweck MR, Leipsic JA, Simonato M, Rogers T, Sathananthan J, Guerrero M, Ternacle J, Wijeysundera HC, Sondergaard L, Barbanti M, Salaun E, Généreux P, Kaneko T, Landes U, Wood DA, Deeb GM, Sellers SL, Lewis J, Madhavan M, Gillam L, Reardon M, Bleiziffer S, O'Gara PT, Rodés-Cabau J, Grayburn PA, Lancellotti P, Thourani VH, Bax JJ, Mack MJ, Leon MB; Heart Valve Collaboratory. Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Aug 2;80(5):545-561. doi: 10.1016/j.jacc.2022.06.002. PMID: 35902178.

Fazzari F, Baggiano A, Fusini L, Ghulam Ali S, Gripari P, Junod D, Mancini ME, Maragna R, Mushtaq S, Pontone G, Pepi M, Muratori M. Early Biological Valve Failure: Structural Valve Degeneration, Thrombosis, or Endocarditis? J Clin Med. 2023 Sep 3;12(17):5740. doi: 10.3390/jcm12175740. PMID: 37685807; PMCID: PMC10488994.